Betnovate 1 mg/g

Betnovate is a topical dermatological solution containing betamethasone, a potent corticosteroid used to treat various skin conditions. Originally developed in the United Kingdom, it is manufactured in multiple countries to meet global demand. The brand is owned by GlaxoSmithKline, a leading pharmaceutical company known for its commitment to healthcare innovation and quality. Betnovate is widely recognized for its effectiveness in managing inflammatory skin disorders.